BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 35260468)

  • 1. Sporadic SARS-CoV-2 cases at the neighbourhood level in Toronto, Ontario, 2020: a spatial analysis of the early pandemic period.
    Obress L; Berke O; Fisman DN; Tuite AR; Greer AL
    CMAJ Open; 2022; 10(1):E190-E195. PubMed ID: 35260468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering SARS-COV-2 vaccine uptake and COVID-19 impacts among First Nations, Inuit and Métis Peoples living in Toronto and London, Ontario.
    Smylie J; McConkey S; Rachlis B; Avery L; Mecredy G; Brar R; Bourgeois C; Dokis B; Vandevenne S; Rotondi MA
    CMAJ; 2022 Aug; 194(29):E1018-E1026. PubMed ID: 35918087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neighbourhood-level socio-demographic characteristics and risk of COVID-19 incidence and mortality in Ontario, Canada: A population-based study.
    van Ingen T; Brown KA; Buchan SA; Akingbola S; Daneman N; Warren CM; Smith BT
    PLoS One; 2022; 17(10):e0276507. PubMed ID: 36264984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 case rates, spatial mobility, and neighbourhood socioeconomic characteristics in Toronto: a spatial-temporal analysis.
    Forsyth J; Wang L; Thomas-Bachli A
    Can J Public Health; 2023 Oct; 114(5):806-822. PubMed ID: 37526916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.
    Bhatt M; Plint AC; Tang K; Malley R; Huy AP; McGahern C; Dawson J; Pelchat M; Dawson L; Varshney T; Arnold C; Galipeau Y; Austin M; Thampi N; Alnaji F; Langlois MA; Zemek RL
    CMAJ Open; 2022; 10(2):E357-E366. PubMed ID: 35414597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of population infection with SARS-CoV-2 in Ontario, Canada, March to June 2020.
    Bolotin S; Tran V; Deeks SL; Peci A; Brown KA; Buchan SA; Ogbulafor K; Ramoutar T; Nguyen M; Thakkar R; DelaCruz R; Mustfa R; Maregmen J; Woods O; Krasna T; Cronin K; Osman S; Joh E; Allen VG
    Euro Surveill; 2021 Dec; 26(50):. PubMed ID: 34915969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between new-onset anosmia and positive SARS-CoV-2 tests among people accessing outpatient testing in Toronto, Ontario: a retrospective cross-sectional study.
    O'Neill B; Kalia S; Gill P; Hum S; Moran-Venegas C; Stoller R; Greiver M; Agarwal P; Kirubarajan A; DeKoven S; Eisen D; Pinto A; Dunn S
    CMAJ Open; 2021; 9(4):E1134-E1140. PubMed ID: 34876415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing concentration of COVID-19 by socioeconomic determinants and geography in Toronto, Canada: an observational study.
    Mishra S; Ma H; Moloney G; Yiu KCY; Darvin D; Landsman D; Kwong JC; Calzavara A; Straus S; Chan AK; Gournis E; Rilkoff H; Xia Y; Katz A; Williamson T; Malikov K; Kustra R; Maheu-Giroux M; Sander B; Baral SD;
    Ann Epidemiol; 2022 Jan; 65():84-92. PubMed ID: 34320380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seropositivity and risk factors for SARS-CoV-2 infection in a South Asian community in Ontario: a cross-sectional analysis of a prospective cohort study.
    Anand SS; Arnold C; Bangdiwala SI; Bolotin S; Bowdish D; Chanchlani R; de Souza RJ; Desai D; Kandasamy S; Khan F; Khan Z; Langlois MA; Limbachia J; Lear SA; Loeb M; Loh L; Manoharan B; Nakka K; Pelchat M; Punthakee Z; Schulze KM; Williams N; Wahi G
    CMAJ Open; 2022; 10(3):E599-E609. PubMed ID: 35790229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 testing, infection and outcomes among Ontario physicians: a descriptive population-based cohort study.
    Liu CW; Jeyakumar N; McArthur E; Sontrop JM; Myran DT; Schwartz KL; Sood MM; Tanuseputro P; Garg AX
    CMAJ Open; 2022; 10(3):E657-E665. PubMed ID: 35853660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for outbreaks of SARS-CoV-2 infection at retirement homes in Ontario, Canada: a population-level cohort study.
    Costa AP; Manis DR; Jones A; Stall NM; Brown KA; Boscart V; Castellino A; Heckman GA; Hillmer MP; Ma C; Pham P; Rais S; Sinha SK; Poss JW
    CMAJ; 2021 May; 193(19):E672-E680. PubMed ID: 33972220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological Characteristics and Transmissibility for SARS-CoV-2 of Population Level and Cluster Level in a Chinese City.
    Yu S; Cui S; Rui J; Zhao Z; Deng B; Liu C; Li K; Wang Y; Yang Z; Li Q; Chen T; Wang S
    Front Public Health; 2021; 9():799536. PubMed ID: 35118044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Testing and Complications Across 6 Waves of the COVID-19 Pandemic Among Individuals Recently Experiencing Homelessness in Ontario, Canada.
    Shariff SZ; Reid JN; Boozary AS; Booth R
    JAMA Netw Open; 2023 May; 6(5):e2312394. PubMed ID: 37155172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
    Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
    BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    COVID-19 National Preparedness Collaborators
    Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postpartum mental illness during the COVID-19 pandemic: a population-based, repeated cross-sectional study.
    Vigod SN; Brown HK; Huang A; Fung K; Barker LC; Hussain-Shamsy N; Wright E; Dennis CL; Grigoriadis S; Gozdyra P; Corsi D; Walker M; Moineddin R
    CMAJ; 2021 Jun; 193(23):E835-E843. PubMed ID: 34099467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a "stay-at-home" policy on SARS-CoV-2 transmission in Toronto, Canada: a mathematical modelling study.
    Yuan P; Li J; Aruffo E; Gatov E; Li Q; Zheng T; Ogden NH; Sander B; Heffernan J; Collier S; Tan Y; Li J; Arino J; Bélair J; Watmough J; Kong JD; Moyles I; Zhu H
    CMAJ Open; 2022; 10(2):E367-E378. PubMed ID: 35440484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
    Post LA; Benishay ET; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh LN; White J; Chaudhury AS; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e25799. PubMed ID: 33475513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations Between Built Environment Factors and SARS-CoV-2 Infections at the Neighbourhood Level in a Metropolitan Area in Germany.
    Schmiege D; Haselhoff T; Ahmed S; Anastasiou OE; Moebus S
    J Urban Health; 2023 Feb; 100(1):40-50. PubMed ID: 36635521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic Variation in the Relationship Between Neighbourhoods' Built Environments and the Spread of COVID-19 in Toronto, Canada.
    Choi KH; Denice P
    Can Stud Popul; 2022; 49(3-4):149-181. PubMed ID: 36068823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.